Zentalis Pharmaceuticals, Inc.
ZNTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001725160
In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Zentalis Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 136
- −8 vs. Q2 2024
- Shares held
- 71.0M
- −881.3K (−1.2%) vs. Q2 2024
- Total value
- $261.2M
- −$33.4M (−11.3%) vs. Q2 2024
- New holders
- 27
- 45 more added
- Sold out
- 35
- 39 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZNTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 114 | $228.9M |
| Q1 2026 | 102 | $101.7M |
| Q4 2025 | 86 | $54.9M |
| Q3 2025 | 99 | $79.7M |
| Q2 2025 | 117 | $64.5M |
| Q1 2025 | 132 | $92.9M |
| Q4 2024 | 142 | $195.2M |
| Q3 2024 | 136 | $261.2M |
| Q2 2024 | 145 | $314.3M |
| Q1 2024 | 142 | $1.34B |
| Q4 2023 | 120 | $1.23B |
| Q3 2023 | 137 | $1.61B |
| Q2 2023 | 134 | $2.32B |
| Q1 2023 | 110 | $1.15B |
| Q4 2022 | 106 | $1.30B |
| Q3 2022 | 121 | $1.27B |
| Q2 2022 | 122 | $1.64B |
| Q1 2022 | 128 | $2.05B |
| Q4 2021 | 139 | $3.61B |
| Q3 2021 | 116 | $2.75B |
| Q2 2021 | 120 | $2.13B |
| Q1 2021 | 95 | $1.58B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Zentalis Pharmaceuticals, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Connor, Clark & Lunn Investment Management Ltd. | 229,138 | $843.2K | 0.00% | +127,868+126.3% | Added |
| Acadian Asset Management LLC | 263,216 | $967.0K | 0.00% | +263,216 | New |
| Charles Schwab Investment Management Inc | 406,210 | $1.49M | 0.00% | −62,203−13.3% | Reduced |
| Boxer Capital, LLC | 450,000 | $1.66M | 0.08% | 00.0% | Unchanged |
| Northern Trust Corp | 474,225 | $1.75M | 0.00% | −21,041−4.2% | Reduced |
| Nuveen Asset Management, LLC | 474,345 | $1.75M | 0.00% | +344,037+264.0% | Added |
| Federated Hermes, Inc. | 483,338 | $1.78M | 0.00% | +857+0.2% | Added |
| JPMorgan Chase & Co | 489,199 | $1.80M | 0.00% | −6,611−1.3% | Reduced |
| 5AM Venture Management, LLC | 490,000 | $1.80M | 0.37% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 505,644 | $1.86M | 0.00% | −121,019−19.3% | Reduced |
| Renaissance Technologies LLC | 556,944 | $2.05M | 0.00% | −104,738−15.8% | Reduced |
| Gsa Capital Partners LLP | 608,585 | $2.24M | 0.17% | +353,384+138.5% | Added |
| Goldman Sachs Group Inc | 634,064 | $2.33M | 0.00% | +14,811+2.4% | Added |
| Bank of America Corp | 775,536 | $2.85M | 0.00% | +267,303+52.6% | Added |
| Millennium Management LLC | 886,086 | $3.26M | 0.00% | +493,478+125.7% | Added |
| Two Sigma Investments, LP | 908,601 | $3.34M | 0.01% | −143,797−13.7% | Reduced |
| Almitas Capital LLC | 960,928 | $3.54M | 1.25% | +960,928 | New |
| Tybourne Capital Management (HK) Ltd | 961,486 | $3.54M | 0.99% | 00.0% | Unchanged |
| Opaleye Management Inc. | 967,000 | $3.56M | 0.59% | +967,000 | New |
| Price T Rowe Associates Inc | 1,036,911 | $3.82M | 0.00% | +113,010+12.2% | Added |
| Woodline Partners LP | 1,055,282 | $3.88M | 0.03% | −461,795−30.4% | Reduced |
| D. E. Shaw & Co., Inc. | 1,128,577 | $4.15M | 0.01% | +888,236+369.6% | Added |
| Two Sigma Advisers, LP | 1,149,400 | $4.23M | 0.01% | +352,500+44.2% | Added |
| State Street Corp | 1,246,613 | $4.59M | 0.00% | −1,805,779−59.2% | Reduced |
| Geode Capital Management, LLC | 1,292,100 | $4.76M | 0.00% | −42,359−3.2% | Reduced |
| MPM Oncology Impact Management LP | 1,465,801 | $5.39M | 0.81% | +15,801+1.1% | Added |
| Primecap Management Co | 1,498,030 | $5.51M | 0.00% | +265,690+21.6% | Added |
| Verition Fund Management LLC | 1,504,320 | $5.54M | 0.04% | +951,500+172.1% | Added |
| Morgan Stanley | 1,611,567 | $5.93M | 0.00% | −339,155−17.4% | Reduced |
| Citadel Advisors LLC | 2,717,521 | $10.0M | 0.01% | −1,785,392−39.6% | Reduced |
| Decheng Capital LLC | 3,108,095 | $11.4M | 2.71% | +37,653+1.2% | Added |
| Vanguard Group Inc | 4,612,707 | $17.0M | 0.00% | −1,042,050−18.4% | Reduced |
| BlackRock, Inc. | 4,761,173 | $17.5M | 0.00% | +4,761,173 | New |
| FMR LLC | 5,075,837 | $18.7M | 0.00% | −3,600,886−41.5% | Reduced |
| Eventide Asset Management, LLC | 8,547,896 | $31.5M | 0.54% | 00.0% | Unchanged |
| Matrix Capital Management Company, LP | 13,959,973 | $51.4M | 2.45% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −1,325,491−100.0% | Sold out |
| Capital International Investors | 0 | $0 | 0.00% | −675,371−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −98,331−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −167,564−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −113,386−100.0% | Sold out |
| Swiss National Bank | 0 | $0 | 0.00% | −104,700−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −93,186−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −71,527−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −48,780−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −40,067−100.0% | Sold out |
| Pennant Investors, LP | 0 | $0 | 0.00% | −32,400−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −32,052−100.0% | Sold out |
| Profund Advisors LLC | 0 | $0 | 0.00% | −30,892−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −29,697−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −24,301−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −22,021−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −21,172−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −21,011−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −20,185−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −14,898−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −14,637−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −14,500−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −12,582−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −12,518−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −11,684−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −10,177−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −7,809−100.0% | Sold out |
| Great West Life Assurance Co | 0 | $0 | 0.00% | −5,018−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −4,038−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −3,500−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −953−100.0% | Sold out |
| C M Bidwell & Associates Ltd | 0 | $0 | 0.00% | −436−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −254−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |